Fund Holdings — Atle Fund Management AB

Total Portfolio Value:
$212.75M
Total Bought:
$58.55M
Total Sold:
$9.28M
Net Transaction:
+$49.27M
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Eli Lilly and Company(LLY)27,14430,564+3,420$24.58M$27.08M12.73%+$2.50M
UnitedHealth Group Incorporated(UNH)31,68035,490+3,810$16.13M$20.75M9.75%+$4.62M
Merck & Co., Inc.(MRK)112,734154,699+41,965$13.96M$17.57M8.26%+$3.61M
Thermo Fisher Scientific Inc.(TMO)19,45822,012+2,554$10.76M$13.62M6.40%+$2.86M
Amgen Inc.(AMGN)27,58928,965+1,376$8.62M$9.33M4.39%+$712.6K
Boston Scientific Corporation(BSX)106,557106,172-385$8.21M$8.90M4.18%+$691.3K
AbbVie Inc.(ABBV)35,61844,486+8,868$6.11M$8.79M4.13%+$2.68M
Stryker Corporation(SYK)19,98323,460+3,477$6.80M$8.48M3.98%+$1.68M
Cencora Inc30,32036,544+6,224$6.83M$8.23M3.87%+$1.39M
Vertex Pharmaceuticals Incorporated(VRTX)15,09516,993+1,898$7.08M$7.90M3.71%+$827.8K
Regeneron Pharmaceuticals, Inc.(REGN)6,8937,028+135$7.24M$7.39M3.47%+$143.4K
Neurocrine Biosciences, Inc.(NBIX)23,63060,607+36,977$3.25M$6.98M3.28%+$3.73M
Alkermes plcSHS(ALKS)68,800236,610+167,810$1.66M$6.62M3.11%+$4.96M
Intra-Cellular Therapies Inc35,84184,578+48,737$2.45M$6.19M2.91%+$3.73M
Harmony Biosciences Holdings, Inc.(HRMY)34,900151,875+116,975$1.05M$6.08M2.86%+$5.02M
UFP Technologies, Inc.(UFPT)9,80018,048+8,248$2.59M$5.72M2.69%+$3.13M
Mirum Pharmaceuticals, Inc.(MIRM)75,200138,321+63,121$2.57M$5.39M2.54%+$2.82M
DexCom, Inc.(DXCM)34,48353,757+19,274$3.91M$3.60M1.69%-$305.8K
Arcellx Inc
COMMON STOCK
22,49640,230+17,734$1.24M$3.36M1.58%+$2.12M
Ionis Pharmaceuticals, Inc.(IONS)40,69182,691+42,000$1.94M$3.31M1.56%+$1.37M
Cardinal Health, Inc.(CAH)27,50027,5000$2.70M$3.04M1.43%+$335.5K
Amicus Therapeutics Inc
COM
148,207275,472+127,265$1.47M$2.94M1.38%+$1.47M
Merus N V30,83750,687+19,850$1.82M$2.53M1.19%+$707.7K
Edwards Lifesciences Corp36,50536,5050$3.37M$2.41M1.13%-$963.0K
Newamsterdam Pharma Company
ORDINARY SHARES
75,794138,983+63,189$1.46M$2.31M1.08%+$851.1K
Summit Therapeutics Inc.(SMMT)086,013+86,013$0$1.88M0.89%+$1.88M
Immunocore Holdings plcADS(IMCR)23,77854,060+30,282$805.8K$1.68M0.79%+$877.1K
Krystal Biotech, Inc.(KRYS)7,6249,202+1,578$1.40M$1.68M0.79%+$275.0K
Autolus Therapeutics plcADS(AUTL)226,145442,423+216,278$787.0K$1.61M0.75%+$819.0K
Corbus Pharmaceuticals Holdings, Inc.(CRBP)39,10069,573+30,473$1.77M$1.44M0.67%-$334.0K
BridgeBio Pharma, Inc.(BBIO)53,43253,4320$1.35M$1.36M0.64%+$6.9K
Soleno Therapeutics Inc026,390+26,390$0$1.33M0.63%+$1.33M
Mersana Therapeutics Inc184,900538,621+353,721$371.6K$1.02M0.48%+$646.3K
Mereo BioPharma Group plcADS(MREO)0200,000+200,000$0$822.0K0.39%+$822.0K
Cabaletta Bio, Inc.(CABA)64,321168,522+104,201$481.1K$795.4K0.37%+$314.3K
Pharvaris N V
COM
34,32834,3280$645.4K$635.8K0.30%-$9.6K
IQVIA Holdings Inc.COM(IQV)13,9840-13,984$2.96M$0—-$2.96M
MacroGenics, Inc.COM(MGNX)143,4070-143,407$609.5K$0—-$609.5K
MORPHIC HLDG INCCOM20,1990-20,199$688.2K$0—-$688.2K
Option Care Health, Inc.COM NEW(OPCH)54,3950-54,395$1.51M$0—-$1.51M
Molina Healthcare, Inc.COM(MOH)9,5000-9,500$2.82M$0—-$2.82M
Page 1 of 1
Atle Fund Management AB — 13F Holdings — Q3 2024 | TickerTrail